-51.7%
FIG vs MRNA
+945.0%
-996.7%
-63.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.2% | +13.1% | -7.9% | +4.8% |
| 7D | -4.7% | +20.6% | -25.3% | -5.3% |
| 30D | +0.5% | +27.1% | -26.6% | -0.4% |
| 3M | -18.4% | +353.4% | -371.8% | -26.2% |
| 6M | +10.9% | +446.3% | -435.4% | -2.3% |
| YTD | -40.8% | +776.2% | -816.9% | -53.6% |
| 1Y | -51.7% | +987.9% | -1,039.6% | -66.6% |
| All | -51.7% | +945.0% | -996.7% | -66.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling